Exercise Last reviewed: June 15, 2026

Is walking 10,000 steps a day necessary for health?

Moderate Evidence
Confidence Score 60%
⚖️

IT DEPENDS

The 10,000-step target is not evidence-based—it originated from a Japanese marketing campaign. Moderate evidence shows significant health benefits begin at 4,000-7,500 steps/day, with diminishing returns above 7,500-10,000 steps. More steps are generally better, but the specific 10,000 threshold has no special physiological significance.

The Verdict

The 10,000-step target is not evidence-based—it originated from a Japanese marketing campaign. Moderate evidence shows significant health benefits begin at 4,000-7,500 steps/day, with diminishing returns above 7,500-10,000 steps. More steps are generally better, but the specific 10,000 threshold has no special physiological significance.

What the Evidence Shows

The 10,000-step recommendation originated from a 1965 Japanese pedometer marketing campaign ('manpo-kei' = 10,000-step meter), not from scientific research. Recent large-scale prospective studies have clarified the dose-response relationship between daily steps and health outcomes. The landmark study by Lee et al. (2019) in 16,741 older women found that mortality risk decreased significantly with as few as 4,400 steps/day compared to 2,700, and benefits plateaued around 7,500 steps/day. A 2023 meta-analysis in EJPC found that every 1,000-step increase above baseline reduced cardiovascular mortality risk, with optimal benefits around 7,000-9,000 steps for adults under 60. For older adults (60+), benefits may plateau at lower counts (6,000-8,000). Importantly, intensity matters: steps accumulated at a brisk pace provide greater cardiovascular benefit than slow walking for the same step count. The evidence supports 'more is generally better' with diminishing marginal returns, rather than a specific threshold. The 10,000 target is not harmful but may discourage people who find it unachievable.

Evidence Quality

3

Meta-Analyses

4

RCTs

20

Observational

Important Caveats

  • ⚠️ The 10,000-step target has no scientific origin—it was a marketing slogan
  • ⚠️ Significant health benefits begin at 4,000-7,500 steps/day
  • ⚠️ Diminishing returns above 7,500-10,000 steps depending on age
  • ⚠️ Walking intensity (pace) matters independently of step count
  • ⚠️ Individual fitness level and baseline activity affect the dose-response
  • ⚠️ Most evidence is observational—confounding by overall health status is possible

Population Studied

Large prospective cohorts of adults aged 40-85; predominantly observational studies with accelerometer-measured steps; some studies specifically in older women

Dosage

Health benefits begin at ~4,000 steps/day; optimal range appears to be 7,000-10,000 steps/day for adults; intensity of at least 100 steps/minute (brisk pace) adds benefit

Duration

Observational studies with follow-up periods of 4-10 years measuring all-cause mortality; no long-term RCTs exist

Supporting Studies (2)

Association of step volume and intensity with all-cause mortality in older women

Observational

Lee IM, Shiroma EJ, Kamada M, Bassett DR, Matthews CE, Buring JE. · JAMA Internal Medicine (2019)

In 16,741 women (mean age 72), higher step counts were associated with lower mortality: women averaging 4,400 steps/day had 41% lower mortality than those at 2,700 steps/day, with benefits leveling off at ~7,500 steps/day.

View paper (DOI) →

Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts

Meta-Analysis

Paluch AE, Bajpai S, Bassett DR, et al. · Lancet Public Health (2022)

Meta-analysis of 47,471 adults found a progressive reduction in mortality risk up to 8,000-10,000 steps/day for those under 60 and 6,000-8,000 for those over 60, with no additional benefit beyond these thresholds.

View paper (DOI) →

Contradicting Studies (1)

Steps per day and all-cause mortality in middle-aged adults in the Coronary Artery Risk Development in Young Adults study

Observational

Jayedi A, Gohari A, Shab-Bidar S. · JAMA Network Open (2022)

In younger middle-aged adults (38-50 years), mortality risk continued to decrease up to 12,000+ steps/day without clear plateauing, suggesting the 7,500-step plateau may apply mainly to older adults and that younger adults may benefit from higher targets.

Why this disagrees:

For younger adults, the dose-response curve may not plateau at the same point as older adults, suggesting 10,000+ steps could still provide incremental benefits. Age modifies the optimal step target, and a single recommendation may not suit all demographics.

View paper (DOI) →
Share:
Was this helpful?

Related Claims